Cargando…

Innate Viral Receptor Signaling Determines Type 1 Diabetes Onset

Heritable susceptibility of the autoimmune disorder, type 1 diabetes (T1D), only partially equates for the incidence of the disease. Significant evidence attributes several environmental stressors, such as vitamin D deficiency, gut microbiome, dietary antigens, and most notably virus infections in t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morse, Zachary J., Horwitz, Marc S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623193/ https://www.ncbi.nlm.nih.gov/pubmed/29018409 http://dx.doi.org/10.3389/fendo.2017.00249

Ejemplares similares

Virus induced dysbiosis promotes type 1 diabetes onset
por: Morse, Zachary J., et al.
Publicado: (2023)

Fresh Ideas, Foundational Experiments (FIFE): Immunology and Diabetes 2016 FIFE Symposium
por: Mouat, Isobel C., et al.
Publicado: (2017)

Virus Infection Is an Instigator of Intestinal Dysbiosis Leading to Type 1 Diabetes
por: Morse, Zachary J., et al.
Publicado: (2021)

Genetics: Is LADA just late onset type 1 diabetes?
por: Hernández, M., et al.
Publicado: (2022)

Nutrition and Obesity in the Pathogenesis of Youth-Onset Type 1 Diabetes and Its Complications
por: March, Christine A., et al.
Publicado: (2021)

Comorbidities in Recent-Onset Adult Type 1 Diabetes: A Comparison of German Cohorts
por: Zaharia, Oana P., et al.
Publicado: (2022)

Determinants of the heart rate variability in type 1 diabetes mellitus
por: Hajdu, Máté, et al.
Publicado: (2023)

Prevalence and Determinants of Painful and Painless Neuropathy in Type 1 Diabetes Mellitus
por: Barbosa, Margarida, et al.
Publicado: (2019)

Editorial: Fresh Ideas, Foundational Experiments: Immunology and Diabetes
por: Spanier, Justin A., et al.
Publicado: (2019)

Genetic glucocorticoid receptor variants differ between ethnic groups but do not explain variation in age of diabetes onset, metabolic and inflammation parameters in patients with type 2 diabetes
por: Ahdi, Mohamed, et al.
Publicado: (2023)

The Folate Cycle As a Cause of Natural Killer Cell Dysfunction and Viral Etiology in Type 1 Diabetes
por: Bayer, Allison L., et al.
Publicado: (2017)

Triple drug therapy with GABA, sitagliptin, and omeprazole prevents type 1 diabetes onset and promotes its reversal in non-obese diabetic mice
por: Lagunas-Rangel, Francisco Alejandro, et al.
Publicado: (2022)

The Impact of COVID-19 Pandemic Lockdown on the Incidence of New-Onset Type 1 Diabetes and Ketoacidosis Among Saudi Children
por: Alaqeel, Aqeel, et al.
Publicado: (2021)

Impact of Covid-19 on the Rate of Diabetic Ketoacidosis in Pediatric New-Onset Type 1 Diabetes
por: Bogale, Kaleb T, et al.
Publicado: (2021)

The Causal Role of Mitochondrial Dynamics in Regulating Innate Immunity in Diabetes
por: Chang, Yen-Hsiang, et al.
Publicado: (2020)

SIRT1 and Estrogen Signaling Cooperation for Breast Cancer Onset and Progression
por: Liarte, Sergio, et al.
Publicado: (2018)

Gene Expression Control by Glucocorticoid Receptors during Innate Immune Responses
por: Xavier, Andre Machado, et al.
Publicado: (2016)

IGF-1 Receptor and Adhesion Signaling: An Important Axis in Determining Cancer Cell Phenotype and Therapy Resistance
por: Cox, Orla T., et al.
Publicado: (2015)

Maternal Diabetes Impairs Insulin and IGF-1 Receptor Expression and Signaling in Human Placenta
por: Tumminia, Andrea, et al.
Publicado: (2021)

Benefits of Sustained Upregulated Unimolecular GLP-1 and CCK Receptor Signalling in Obesity-Diabetes
por: Tanday, Neil, et al.
Publicado: (2021)

Short-term use of CGM in youth onset type 2 diabetes is associated with behavioral modifications
por: Manfredo, Jacquelyn, et al.
Publicado: (2023)

Guidance for high-dose vitamin D supplementation for prolonging the honeymoon phase in children and adolescents with new-onset type 1 diabetes
por: Nwosu, Benjamin Udoka
Publicado: (2022)

Are the determinants of the progression to type 2 diabetes and regression to normoglycemia in the populations with pre-diabetes the same?
por: Alizadeh, Zeinab, et al.
Publicado: (2022)

Incidence of Type 2 Diabetes in Kuwaiti Children and Adolescents: Results From the Childhood-Onset Diabetes Electronic Registry (CODeR)
por: Al-Kandari, Hessa, et al.
Publicado: (2019)

Genetic testing for misclassified monogenic diabetes in Māori and Pacific peoples in Aōtearoa New Zealand with early-onset type 2 diabetes
por: Toomata, Zanetta, et al.
Publicado: (2023)

PSAT118 Elevated Serum IgA at Onset of Type 1 Diabetes in Children
por: Thakkar, Amruta, et al.
Publicado: (2022)

Case Report: Onset of Type 1 Diabetes Mellitus in a Patient With Ulcerative Colitis and Sjogren’s Syndrome Under Euthyroid Hashimoto’s Thyroiditis
por: Takahashi, Kaio, et al.
Publicado: (2022)

First Case Report of Maturity-Onset Diabetes of the Young Type 4 Pedigree in a Chinese Family
por: Deng, Mingqun, et al.
Publicado: (2019)

The Clinical Characteristics and Gene Mutations of Maturity-Onset Diabetes of the Young Type 5 in Sixty-One Patients
por: Ge, Shenghui, et al.
Publicado: (2022)

Hypoglycemia in Type 2 Diabetes: Current Controversies and Changing Practices
por: Bloomgarden, Zachary T., et al.
Publicado: (2012)

Metabolic Functions of G Protein-Coupled Receptors and β-Arrestin-Mediated Signaling Pathways in the Pathophysiology of Type 2 Diabetes and Obesity
por: Oliveira de Souza, Camila, et al.
Publicado: (2021)

Prevalence of Metabolic Syndrome and Its Determinants in Newly-Diagnosed Adult-Onset Diabetes in China: A Multi-Center, Cross-Sectional Survey
por: Li, Xia, et al.
Publicado: (2019)

Late-Onset Type 1 Diabetes Mellitus and Unexplained Subcutaneous Lesions
por: Tunc, Malik A, et al.
Publicado: (2023)

The Prevalence of Islet Autoantibodies in Children and Adolescents With Type 1 Diabetes Mellitus: A Global Scoping Review
por: Ross, Carlo, et al.
Publicado: (2022)

Early-Onset Type 2 Diabetes Mellitus
por: Sunny, Angel
Publicado: (2021)

Multiomics signatures of type 1 diabetes with and without albuminuria
por: Clos-Garcia, Marc, et al.
Publicado: (2022)

It Is Time to Consider Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes in Youth
por: Oberle, Megan M., et al.
Publicado: (2019)

Metabolic remodeling of glycerophospholipids acts as a signature of dulaglutide and liraglutide treatment in recent-onset type 2 diabetes mellitus
por: Du, Juan, et al.
Publicado: (2023)

Dapagliflozin Attenuates Renal Tubulointerstitial Fibrosis Associated With Type 1 Diabetes by Regulating STAT1/TGFβ1 Signaling
por: Huang, Fengjuan, et al.
Publicado: (2019)

Treatment of Type 2 Diabetes by Free Fatty Acid Receptor Agonists
por: Watterson, Kenneth R., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gr5v7kl1uc57bmllsilrmhl224